Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage

Journal of Neuroscience

Volumn 28, Issue 48, 2008, Pages 12736-12747

  Rathore, Khizr I ^a   Kerr, Bradley J ^a   Redensek, Adriana ^a   López Vales, Rubèn ^a   Suh, Young Jeong ^a   Ponka, Prem ^b   David, Samuel ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

CNS injury; Free radicals; Hemorrhage; Inflammation; Iron chelation; Macrophage

Indexed keywords

CERULOPLASMIN; FERROUS ION; FREE RADICAL; IRON CHELATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DEMYELINATION; DETOXIFICATION; HEMOSTASIS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MACROPHAGE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; SPINAL CORD MOTONEURON; TISSUE DEGENERATION;

ANIMALS; ANTIOXIDANTS; CERULOPLASMIN; DISEASE MODELS, ANIMAL; HEMORRHAGE; IRON; IRON METABOLISM DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 58149373436     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3649-08.2008     Document Type: Article

References (61)

1. Bao F, Liu D (2004) Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: protection by a metalloporphyrin. Neuroscience 126:285-295.
2. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23:635-659.
3. Bento I, Peixoto C, Zaitsev VN, Lindley PF (2007) Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites. Acta Crystallogr D Biol Crystallogr 63:240-248.
4. Bielli P, Calabrese L (2002) Structure to function relationships in ceruloplasmin: a "moonlighting" protein. Cell Mol Life Sci 59:1413-1427.
5. Braughler JM, Hall ED (1992) Involvement of lipid peroxidation in CNS injury. J Neurotrauma 9 [Suppl 1]:S1-S7.
6. Cornejo P, Varela P, Videla LA, Fernández V (2005) Chronic iron overload enhances inducible nitric oxide synthase expression in rat liver. Nitric Oxide 13:54-61.
7. De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J (2007) Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26:2823-2831.
8. Earley CJ, Ponnuru P, Wang X, Patton SM, Conner JR, Beard JL, Taub DD, Allen RP (2008) Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. Sleep 31:847-852.
9. Eaton JW, Qian M (2002) Molecular bases of cellular iron toxicity. Free Radic Biol Med 32:833-840.
10. Feroze-Merzoug F, Berquin IM, Dey J, Chen YQ (2002) Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and beta-actin in quantitative RNA analyses. Biotechniques 32:776-778, 780, 782.
11. Ganz T (2006) Hepcidin: a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306:183-198.
12. Ghasemlou N, Kerr BJ, David S (2005) Tissue displacement and impact force are important contributors to outcome after spinal cord contusion injury. Exp Neurol 196:9-17.
13. Gutteridge JM (1978) Caeruloplasmin: a plasma protein, enzyme, and antioxidant. Ann Clin Biochem 15:293-296.
14. Hausmann ON (2003) Post-traumatic inflammation following spinal cord injury. Spinal Cord 41:369-378.
15. Hellman NE, Gitlin JD (2002) Ceruloplasmin metabolism and function. Annu Rev Nutr 22:439-458.
16. Hermanns S, Reiprich P, Müller HW (2001) A reliable method to reduce collagen scar formation in the lesioned rat spinal cord. J Neurosci Methods 110:141-146.
17. Hintze KJ, Theil EC (2006) Cellular regulation and molecular interactions of the ferritins. Cell Mol Life Sci 63:591-600.
18. Jeong SY, David S (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278:27144-27148.
19. Jeong SY, David S (2006) Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice. J Neurosci 26:9810-9819.
20. Keller JN, Hanni KB, Markesbery WR (1999) 4-hydroxynonenal increases neuronal susceptibility to oxidative stress. J Neurosci Res 58:823-830.
21. Klapka N, Hermanns S, Straten G, Masanneck C, Duis S, Hamers FP, Müller D, Zuschratter W, Müller HW (2005) Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci 22:3047-3058.
22. Klimtová I, Simůnek T, Mazurová Y, Kaplanová J, Sterba M, Hrdina R, Gersl V, Adamcová M, Ponka P (2003) A study of potential toxic effects after repeated 10-week administration of a new iron chelator - salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits. Acta Medica (Hradec Kralove) 46:163-170.
23. Knutson M, Wessling-Resnick M (2003) Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 38:61-88.
24. Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M (2003) Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102:4191-4197.
25. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102:1324-1328.
26. Liu D, Liu J, Wen J (1999) Elevation of hydrogen peroxide after spinal cord injury detected by using the Fenton reaction. Free Radic Biol Med 27:478-482.
27. Liu D, Ling X, Wen J, Liu J (2000) The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 75:2144-2154.
28. Liu D, Liu J, Sun D, Wen J (2004) The time course of hydroxyl radical formation following spinal cord injury: the possible role of the iron-catalyzed Haber-Weiss reaction. J Neurotrauma 21:805-816.
29. Lymboussaki A, Pignatti E, Montosi G, Garuti C, Haile DJ, Pietrangelo A (2003) The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J Hepatol 39:710-715.
30. MacKenzie EL, Iwasaki K, Tsuji Y (2008) Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 10:997-1030.
31. Mautes AE, Kim DH, Sharp FR, Panter S, Sato M, Maida N, Bergeron M, Guenther K, Noble LJ (1998) Induction of heme oxygenase-1 (HO-1) in the contused spinal cord of the rat. Brain Res 795:17-24.
32. Mazumder B, Mukhopadhyay CK, Prok A, Cathcart MK, Fox PL (1997) Induction of ceruloplasmin synthesis by IFN-gamma in human monocytic cells. J Immunol 159:1938-1944.
33. Meguro R, Asano Y, Iwatsuki H, Shoumura K (2003) Perfusion-Perls and -Turnbull methods supplemented by DAB intensification for nonheme iron histochemistry: demonstration of the superior sensitivity of the methods in the liver, spleen, and stomach of the rat. Histochem Cell Biol 120:73-82.
34. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767.
35. Moura E, Noordermeer MA, Verhoeven N, Verheul AF, Marx JJ (1998) Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 92:2511-2519.
36. Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26:523-530.
37. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093.
38. Patel BN, David S (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272:20185-20190.
39. Patel BN, Dunn RJ, David S (2000) Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 275:4305-4310.
40. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22:6578-6586.
41. Picard V, Govoni G, Jabado N, Gros P (2000) Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool. J Biol Chem 275:35738-35745.
42. Richardson DR, Ponka P (1998a) Orally effective iron chelators for the treatment of iron overload disease: the case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs. J Lab Clin Med 132:351-352.
43. Richardson DR, Ponka P (1998b) Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron-chelating agents for the treatment of iron overload disease. J Lab Clin Med 131:306-315.
44. Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2:406-414.
45. Santos MM, de Sousa M, Rademakers LH, Clevers H, Marx JJ, Schilham MW (2000) Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1. Am J Pathol 157:1883-1892.
46. Schültke E, Kendall E, Kamencic H, Ghong Z, Griebel RW, Juurlink BH (2003) Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 20:583-591.
47. Simůnek T, Boer C, Bouwman RA, Vlasblom R, Versteilen AM, Sterba M, Gersl V, Hrdina R, Ponka P, de Lange JJ, Paulus WJ, Musters RJ (2005) SIH - a novel lipophilic iron chelator - protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. J Mol Cell Cardiol 39:345-354.
48. Simunek T, Sterba M, Popelova O, Kaiserova H, Potacova A, Adamcova M, Mazurova Y, Ponka P, Gersl V (2008a) Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity. Hemoglobin 32:207-215.
49. Simůnek T, Sterba M, Popelová O, Kaiserová H, Adamcová M, Hroch M, Hasková P, Ponka P, Gersl V (2008b) Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. Br J Pharmacol 155:138-148.
50. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94:9866-9868.
51. Sterba M, Simůnek T, Mazurová Y, Adamcová M, Popelová O, Kaplanova J, Ponka P, Gersl V (2005) Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits. Hum Exp Toxicol 24:581-589.
52. Sterba M, Popelová O, Simunek T, Mazurová Y, Potácová A, Adamcová M, Kaiserová H, Ponka P, Gersl V (2006) Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity. J Pharmacol Exp Ther 319:1336-1347.
53. Sterba M, Popelová O, Simůnek T, Mazurová Y, Potácová A, Adamcová M, Guncová I, Kaiserová H, Palicka V, Ponka P, Gersl V (2007) Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH). Toxicology 235:150-166.
54. Usatyuk PV, Parinandi NL, Natarajan V (2006) Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. J Biol Chem 281:35554-35566.
55. Vassiliev V, Harris ZL, Zatta P (2005) Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev 49:633-640.
56. Xu J, Kim GM, Chen S, Yan P, Ahmed SH, Ku G, Beckman JS, Xu XM, Hsu CY (2001) iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma 18:523-532.
57. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, Haile DJ (2002) Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 277:39786-39791.
58. Yang F, Naylor SL, Lum JB, Cutshaw S, McCombs JL, Naberhaus KH, McGill JR, Adrian GS, Moore CM, Barnett DR (1986) Characterization, mapping, and expression of the human ceruloplasmin gene. Proc Natl Acad Sci U S A 83:3257-3261.
59. Zaitsev VN, Zaitseva I, Papiz M, Lindley PF (1999) An X-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multi-copper oxidase in the plasma. J Biol Inorg Chem 4:579-587.
60. Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54:795-804.
61. Zoller H, Theurl I, Koch R, Kaser A, Weiss G (2002) Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Dis 29:488-497.